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ABSTRACT: Introduction: Little is known about what consti-
tutes appropriate diagnostic testing in patients with distal sym-
metric polyneuropathy (DSP). Methods: Utilizing an ICD-9
screening method and medical record abstraction, we deter-
mined the number of new cases of DSP within community neu-
rology practices in Nueces County, Texas. We then compared 2
case capture methods (ICD-9 vs. all-case review screening).
Results: The ICD-9 case capture method identified 52 cases
over a 3-month period. Comparing case capture methods, the
ICD-9 method identified 16 of 17 cases identified by the all-
case review method (94%). The ICD-9 method required screen-
ing of 84% fewer charts compared with the all-case review.
Conclusions: Many new cases of DSP occur each month
within Nueces County. The ICD-9 screening technique com-
bined with medical abstraction is an efficient method to identify
new DSP cases in this community. These findings are critical
for future epidemiological investigations into patients with DSP.
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Although there are many types of peripheral neu-
ropathy, by far the most common is distal symmet-
ric polyneuropathy (DSP).1 DSP is a disorder char-
acterized by a combination of features, including
pain, numbness, paresthesias, and/or weakness,
starting in the feet and progressing proximally in a
stocking-glove fashion.2 Patients often have dis-
abling pain and balance difficulties. Due to lack of
sensation in the feet, injuries also occur that can
result in ulcerations or even osteonecrosis.3 DSP is
a common, disabling condition that has been
under-studied to date.
Despite the fact that DSP is common, little is
known about its causes, and uncertainty exists
regarding the appropriate diagnostic evaluation.
Johannsen et al. followed 198 patients with symp-
toms suggestive of polyneuropathy who were
referred for electrodiagnostic evaluation.4 The
investigators found that diabetes and alcohol abuse
were the most common etiologies, accounting for
51% of cases. However, a quarter of the patients
remained with an idiopathic diagnosis.
Lubec et al. reported similar results in those
discharged from the hospital with a diagnosis of
neuropathy.5 Focusing on those without a clear di-
agnosis based on history and examination, Dyck
et al. demonstrated that, in a single tertiary referral
center, a significant proportion of patients with
neuropathy likely have a genetic cause.6 With
regard to diagnostic tests, Fagius et al. revealed
that most laboratory tests have a low yield in those
patients with no clear cause of neuropathy based
on clinical history.7 The only tests with a yield
>5% included the glucose tolerance test and se-
rum protein electrophoresis. Similarly, Smith et al.
revealed that the glucose tolerance test and serum
vitamin B12 level were the only tests with a higher
yield than expected from the general population.8
However, all of these studies were performed in
tertiary care settings, and none utilized a strict def-
inition of neuropathy. Moreover, none of the stud-
ies investigated how often diagnostic tests change
the suspected etiology and/or management of
these patients. Further emphasizing the need for
future studies, we have recently shown that the
evaluation of DSP is highly variable and costly.9,10
Our long-term goal is to perform a population-
based study examining the causes and diagnostic
evaluation of DSP. To inform future sample size
calculations, we sought to determine the number
of DSP cases that present within a community with-
out an academic medical center over a defined
time period. We next compared an efficient case
capture method [the ninth revision of the Interna-
tional Classification of Diseases (ICD-9) identifica-
tion with subsequent medical record abstraction]
to an all-case review method followed by medical
record abstraction. Finally, we investigated the va-
lidity of DSP classification by a research coordina-
tor when compared with that by a neuromuscular
specialist.
METHODS
Population. This study was designed to capture all
new patients with DSP (i.e., no previous diagnosis
of DSP) seen by neurologists within Nueces
County, Texas. Nueces County is on the Gulf
Coast, and the vast majority of its residents live in
the city of Corpus Christi. Corpus Christi is 145
miles from San Antonio and greater than 200
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miles from Houston. This significant distance from
nearby major cities makes Corpus Christi the re-
gional referral center for the area. Nueces County
residents are unlikely to receive their medical care
from the surrounding tertiary referral centers,
which makes nearly complete case capture possi-
ble. This study was approved by the institutional
review board of the University of Michigan.
We contacted all 11 practicing community neu-
rologists within the 3 neurology practices in
Nueces County to solicit study participation. Nine
agreed to participate. Of the remaining 2 physi-
cians, one does not see patients with neuropathy
and the other is in the process of retiring.
Neuropathy Definition. The study population
included patients with a new diagnosis of DSP. We
defined DSP as patients who met the Diabetes
Control and Complications Trial (DCCT) defini-
tion. This requires 2 of the following criteria:
neuropathic symptoms [self-report of pain (burn-
ing, electric, shooting), numbness, tingling in the
feet and/or legs]; decreased distal sensation on
neurological examination; or decreased or absent
ankle jerks. We also required that the physician
document neuropathy within the medical record.
To eliminate patients with neuropathy subtypes
other than DSP, we excluded patients with atypical
features such as acute/subacute/relapsing presen-
tation, motor predominance, asymmetry (focal,
multifocal), non–length dependence, and those
with prominent autonomic dysfunction. We also
excluded patients who were not from Nueces
County, were seen in the hospital only, or were
seen for electrodiagnostic testing only.
Case Capture Methods. We utilized and compared
2 separate methods for identifying patients with
DSP. The first method was to use ICD-9 codes fol-
lowed by medical record abstraction to identify
possible cases. The ICD-9 codes included were
250.60, 356.1, 356.2, 356.4, 356.8, 356.9, 357.1,
357.2, 357.3, 357.4, 357.5, 357.6, 357.7, 357.82,
357.89, 357.9, 729.5, and 782.0. These codes
include peripheral neuropathy codes as well as
symptomatic codes for paresthesias and pain in the
extremities (Table 1). This method was employed
for a 3-month period from January 1, 2010
through March 31, 2010. The second method,
termed all-case review, involved screening of all
new patient medical records with subsequent medi-
cal record abstraction over a 1-month period from
February 1, 2010 through February 28, 2010.
Medical Record Abstraction. Medical records for
cases identified by either screening method were
abstracted by a trained research coordinator. Infor-
mation abstracted included demographics, clinical
characteristics, each of the 3 DCCT criteria,
and the 5 study exclusion criteria (Table 2). The
entire outpatient medical record was reviewed,
including the initial visit and any subsequent
follow-up visits.
Twenty patients, randomly selected from those
identified using the ICD-9 screening method, were
abstracted by both the research coordinator and a
neurologist with fellowship training in neuromus-
cular disease.
Statistical Analysis. Cases identified by the ICD-9
case capture method within the month of February
were compared with the cases identified by the all-
case review method during the same time period.






250.60 Diabetes with neurologic complications 2
356.1 Peroneal muscular atrophy 0
356.2 Hereditary sensory neuropathy 0
356.4 Idiopathic progressive polyneuropathy 0
356.8 Other specified idiopathic
peripheral neuropathy
0
356.9 Unspecified idiopathic peripheral
neuropathy
40
357.1 Polyneuropathy in collagen
vascular disease
0
357.2 Polyneuropathy in diabetes 8
357.3 Polyneuropathy in malignant disease 0
357.4 Polyneuropathy in other diseases
classified elsewhere
0
357.5 Alcoholic neuropathy 0
357.6 Polyneuropathy due to drugs 0
357.7 Polyneuropathy due to other toxic agents 0
357.82 Critical illness polyneuropathy 0
357.89 Other inflammatory and toxic neuropathy 0
357.9 Unspecified inflammatory and
toxic neuropathies
0
729.5 Pain in limb 1
782.0 Disturbance of skin sensation 1
Table 2. Demographics of the 52 patients identified by the ICD-9
case-capture method over a 3-month time period in Nueces
County, Texas.





Medicare and Medicaid 13.5%
HMO, PPO, private and Medicare 59.6%
HMO, PPO, private 19.2%
Family history of neuropathy 0%
Neuropathic pain 57.7%
Muscle weakness on examination 17.3%
HMO, health maintenance organization; PPO, preferred provider
organization.
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The validity of the research coordinator’s classifica-
tion of each of the DCCT criteria and the overall
classification of DSP were assessed by comparing
the research coordinator’s abstraction results to
the neuromuscular specialist’s results (i.e., the
‘‘gold standard’’), and expressed as sensitivity and
specificity. All analyses were performed using SAS
(version 9.2).
RESULTS
From January 1, 2010 to March 31, 2010 there
were 1167 new patient visits within the 3 neurology
practices. The ICD-9 screening technique identi-
fied 189 neuropathy patients (16.2%). Of these
patients, 89 were excluded for the following rea-
sons: out-of-county residence; previous diagnosis of
DSP; hospital-only cases; or patients seen only for
electrodiagnostic testing (Fig. 1). Of the 100
remaining patients, 52 (52%) met the DCCT clini-
cal definition of DSP based on the medical record
abstraction.
Of the 52 captured DSP cases, the mean age of
the population was 64.9 (SD 13.1) years, and
55.8% were women (Table 2). There was a wide
range of health insurance, and 73.1% of patients
received at least partial coverage with Medicare.
None of the patients had a family history of neu-
ropathy, the majority suffered from neuropathic
pain (57.7%), and 17.3% had distal weakness on
examination.
Comparison of Case Capture Methods. When the
ICD-9 case capture method was restricted to the
time period of February 1, 2010 through February
28, 2010, we found that there were 66 patients
with a qualifying ICD-9 diagnosis out of a total of
404 new patient visits (16.3%). Of these 66 cases,
36 were excluded for the same reasons as listed
earlier. Of the 30 remaining cases, 16 (53.3%) had
DSP based on the results of the medical record
abstraction.
By comparison, the second method (all-case
review) identified a total of 404 new patient visits
between February 1, 2010 and February 28, 2010.
One hundred eighty-two of the 404 total new
patient cases were excluded based on the exclu-
sion criteria. Of the remaining 222 patients, 17
cases (7.7%) of DSP were identified based on the
medical record abstraction.
Thus, the ICD-9 case capture method identified
16 of the 17 DSP cases (94%) identified by the all-
case review method for the same time period
(Fig. 2). The one missed case was a patient with a
chief complaint unrelated to neuropathy, who was
incidentally found to have DSP on further inquiry
and examination.
Validity of DSP Classification by Research Coordina-
tor. The abstraction by the research coordinator
revealed a sensitivity of 100% and a specificity of
88% for the classification of patients as meeting
the definition of DSP when compared with the
neuromuscular specialist (Table 1). When evaluat-
ing the individual inclusion criteria, we found a
sensitivity of 69% for neuropathic symptoms, 90%
for sensory examination, and 100% for reflex
examination. Similarly, we found a specificity of
86% for neuropathic symptoms, 100% for sensory
examination, and 100% for reflex examination.
DISCUSSION
Utilizing an ICD-9 case capture method, we identi-
fied 52 patients who met a strict definition of DSP
over a 3-month time period within this community.
The efficient ICD-9 case capture method resulted
in the identification of 94% of the cases identified
by a more laborious all-case review method. Fur-
ther, we found high validity between a research co-
ordinator and a neuromuscular specialist in the
classification of DSP cases. These results indicate
that DSP case capture can be performed in an
efficient manner within community neurology
practices in future epidemiological studies.
This investigation has demonstrated that the
ICD-9 case capture method is an efficient screen-
ing technique. The all-case review method was
labor-intensive and only identified 1 additional
case (6%) meeting our criteria when compared
with the ICD-9 method. In fact, 338 more charts
were screened with the all-case review method to
FIGURE 1. Flowchart of the ICD-9 screening method over a 3-
month period. DSP, distal symmetric polyneuropathy. [Color fig-
ure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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identify this one case. We also found that ICD-9
screening alone is not adequate for identifying
cases, because about half of those identified by the
ICD-9 code alone did not meet the DCCT criteria.
Therefore, the most efficient and rigorous
approach for case capture is to combine an ICD-9
screening method with medical record abstraction
for the specific DCCT criteria.
By comparing the classification of a trained
research coordinator to that of a neuromuscular
specialist, we found that the coordinator classified
cases with a high sensitivity and specificity. The cri-
terion with the lowest sensitivity and specificity was
neuropathic symptoms, but this did not signifi-
cantly affect the overall classification of cases. The
neurological sensory and reflex examinations both
had high sensitivity and specificity. This finding is
important to allow efficient medical chart abstrac-
tion by research coordinators for planned larger
population-based studies of DSP.
In contrast to earlier work, we determined the
optimal screening method to identify the vast ma-
jority of new cases of DSP in multiple clinics in an
efficient manner. This will allow us to efficiently
identify a large number of patients with DSP and
to understand the population from which they
were identified. Previous studies identified patients
who came to their tertiary care clinic, hospital, or
electrodiagnostic laboratory without attempting to
capture all cases in a defined geographic area.4,5,7,8
Furthermore, our study focused on community
neurology patients, whereas previous work
reported on those from tertiary care centers.
Because most patients with DSP are seen by
community neurologists, this population is particu-
larly important to study and will likely yield more
generalizable results. Finally, we required a system-
atic and rigorous definition of DSP.
Limitations to this work include the fact that
some of the patients who did not meet the strin-
gent DCCT criteria for neuropathy likely had neu-
ropathy. Some patients with neuropathy may never
fulfill the criteria, and some may have had incom-
plete data in the medical record to ascertain the
criteria. On the other hand, physicians may overes-
timate neuropathy based on clinical features
alone.11 This may be in part due to limitations in
the clinical criteria physicians use such as reflex
assessment, especially in an older population. Fur-
thermore, by not including electrodiagnostic stud-
ies in the definition of neuropathy, the specificity
of the DSP diagnosis likely decreases. However,
including these tests within the definition of neu-
ropathy would not allow the study of the impact of
these tests on the DSP evaluation nor the study of
patients with DSP and a normal electrodiagnostic
study. A previous systematic review recommended
that a clinical definition of neuropathy can be
used in epidemiologic studies.12
Another limitation is that not all patients had
their medical record abstraction done by a neuro-
muscular specialist, and only a small number of
charts were used to assess the reliability of the
research coordinator’s ability to classify neuropa-
thy. Because the trained research coordinator
properly classified cases with high accuracy, this is
not likely to change our results significantly. We
also miss all DSP cases that are never seen by a
FIGURE 2. Flowchart showing the comparison of the (A) ICD-9 screening method with the (B) all-case review method over a 1-month
period. DSP, distal symmetric polyneuropathy. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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neurologist, and therefore this work does not per-
tain to this population. Our results were obtained
from within Nueces County; it is unclear whether
they are generalizable to other areas of the coun-
try. No cases identified had a family history of neu-
ropathy recorded. This is surprising given the fact
that inherited neuropathy is the cause of a signifi-
cant proportion of DSP cases.6 Potential explana-
tions include the absence of a detailed family
history or its documentation, or a lower prevalence
of inherited causes of DSP in this population of
patients from routine neurology practices in Texas.
As a result, inherited neuropathy cannot be
excluded as a potential cause of DSP in these
patients.
In this study we have defined an efficient case
capture method for future epidemiologic DSP
research that includes an ICD-9 screening method
in combination with medical abstraction. Future
work will aim to enhance our understanding of the
causes and diagnostic evaluations in patients with
DSP.
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